Skip to content

Transcranial Static Magnetic Field Stimulation of Frontal Cortex

Modulation of Frontal Cortical Activity With Transcranial Static Magnetic Field Stimulation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03244501
Enrollment
24
Registered
2017-08-09
Start date
2017-08-08
Completion date
2017-09-15
Last updated
2017-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

tSMS, Transcranial Static Magnetic Field Stimulation, healthy control

Brief summary

The purpose of this study is to see if a new brain stimulation technique, static magnetic field stimulation (tSMS), which involves holding a static neodymium magnet over the scalp, can influence normal rhythms of brain activity.

Detailed description

The investigator's primary objective is to determine the feasibility of modifying frontal brain activity using static magnetic fields. The investigator's will be examining the effects of static magnetic field of the spectral power of EEG data with healthy human participants. This is a within-subjects design, where each participant will receive sham and active stimulation on the left and right frontal cortex. EEG data will be collected during each stimulation.

Interventions

OTHERActive tSMS

A cylindrical neodymium magnet is placed above the scalp.

A cylindrical piece of nonferrous metal (brass). This is not attracted to magnets, and is identical in weight and appearance to active magnets.

Sponsors

University of North Carolina, Chapel Hill
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)

Masking description

This is a double-blind study, meaning that neither the participant nor the experimenter knows what kind of stimulation the participant is receiving. An unblinded monitor (separate from the staff that interacts with the participant) is responsible for providing the study coordinator with the active and sham magnet sequence. Each magnet has a number; the study coordinator is not aware which number corresponds to active or sham magnets.

Intervention model description

All participants will receive three stimulations: left frontal, right frontal, and sham tSMS.

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
Yes

Inclusion criteria

* Right-handed, healthy, 18+ years old * Capacity to understand all relevant risks and potential benefits of the study (informed consent) * Willing to comply with all study procedures and be available for the duration of the study - Speak and understand English

Exclusion criteria

* Medical history of Psychological/Emotional Disorders (depression, anxiety, bipolar, etc.) * (For females) Pregnancy or breast feeding * Diagnosis of eating disorder (current or within the past 6 months) * Diagnosis of Obsessive-Compulsive Disorder (lifetime) Attention Deficit Hyperactivity Disorder (currently under treatment) * Neurological disorders and conditions, including, but not limited to: * History of epilepsy * Seizures (except childhood febrile seizures and Electroconvulsive therapy-induced seizures) * Dementia * History of stroke * Parkinson's disease * Multiple sclerosis * Cerebral aneurysm * Brain tumors * Medical or neurological illness or treatment for a medical disorder that could interfere with study participation (e.g., unstable cardiac disease, HIV/AIDS, malignancy, liver or renal impairment) * Prior brain surgery Any brain devices/implants, including cochlear implants and aneurysm clips * Any metal in/on the body, e.g., dental braces, glasses, piercings * Traumatic brain injury * Thick hair that would create distance between the magnet and the scalp * Taking hormonal birth control or hormonal supplements (e.g., testosterone injections) - Anything that, in the opinion of the investigator, would place the participant at increased risk or preclude the participant's full compliance with or completion of the study

Design outcomes

Primary

MeasureTime frameDescription
Electroencephalogram (EEG) Spectral Power4 minutes before stimulation, 10 minutes during stimulation, and 2 minutes after stimulationChanges in the spectral power of the EEG before (2 min eyes-closed, 2 min eyes-open), during (eyes-open), and after stimulation (eyes-open)

Secondary

MeasureTime frameDescription
Heart Rate Variability4 minutes before stimulation, 10 minutes during stimulation, and 2 minutes after stimulationChange in the ratio between the power in low frequency band and the power in high frequency band. As this outcome variable is a ratio between two items that are measured in microvolt\^2, the ratio does not have a unit of measure.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026